Effect of Abdominal Wall Injections on Abdominal Pain

Conditions

• Anterior Cutaneous Nerve Entrapment Syndrome

Eligibility Criteria

Sex

ALL

Age

18 Years - 100 Years

Healthy Volunteers

Accepted

Interventions

• Abdominal wall injections with lidocaine 2% — DRUG
  Injections will be administered for patient who are identified as having abdominal wall pain.

Study Details

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.

Key Dates

Start date

Jan 1, 2023

Status verified

Aug 2025

Primary completion

Dec 31, 2025

Completion

Dec 31, 2025

Study Design

Enrollment

45 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Abdominal wall injections for abdominal wall pain
  Patients with abdominal pain who are suspected of having abdominal wall pain.

Primary Outcome Measure

1) To measure the change in abdominal wall pain 1-week, 1-month and 3-months following abdominal wall injections, with improvement defined as a 50% reduction in baseline pain score measured using an 11-point numeric scale. [ Time Frame: 12 weeks ]

Central Contacts

• Sophia Lichenstein-Hill, DNP
  5038801235
  [email protected]

Locations (2)

Find similar trials in Portland, OR